Geode Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.1M | Buy |
1,193,112
+59,347
| +5% | +$2.59M | ﹤0.01% | 1400 |
|
|
2025
Q1 | $31M | Buy |
1,133,765
+28,278
| +3% | +$774K | ﹤0.01% | 1654 |
|
|
2024
Q4 | $44.5M | Buy |
1,105,487
+52,263
| +5% | +$2.1M | ﹤0.01% | 1499 |
|
|
2024
Q3 | $49.9M | Sell |
1,053,224
-996
| -0.1% | -$47.2K | ﹤0.01% | 1428 |
|
|
2024
Q2 | $31.5M | Buy |
1,054,220
+88,520
| +9% | +$2.64M | ﹤0.01% | 1666 |
|
|
2024
Q1 | $38.8M | Buy |
965,700
+85,185
| +10% | +$3.42M | ﹤0.01% | 1518 |
|
|
2023
Q4 | $22.4M | Buy |
880,515
+46,288
| +6% | +$1.18M | ﹤0.01% | 1838 |
|
|
2023
Q3 | $11.6M | Buy |
834,227
+32,942
| +4% | +$458K | ﹤0.01% | 2170 |
|
|
2023
Q2 | $18.4M | Buy |
801,285
+20,456
| +3% | +$470K | ﹤0.01% | 1898 |
|
|
2023
Q1 | $23.1M | Buy |
780,829
+33,758
| +5% | +$1M | ﹤0.01% | 1694 |
|
|
2022
Q4 | $18.6M | Buy |
747,071
+45,849
| +7% | +$1.14M | ﹤0.01% | 1817 |
|
|
2022
Q3 | $15.3M | Buy |
701,222
+25,375
| +4% | +$552K | ﹤0.01% | 1935 |
|
|
2022
Q2 | $13.3M | Buy |
675,847
+52,077
| +8% | +$1.03M | ﹤0.01% | 2048 |
|
|
2022
Q1 | $26.4M | Buy |
623,770
+3,728
| +0.6% | +$158K | ﹤0.01% | 1699 |
|
|
2021
Q4 | $39.4M | Buy |
620,042
+20,172
| +3% | +$1.28M | ﹤0.01% | 1483 |
|
|
2021
Q3 | $35.2M | Buy |
599,870
+258,328
| +76% | +$15.2M | ﹤0.01% | 1569 |
|
|
2021
Q2 | $16.6M | Buy |
341,542
+154,884
| +83% | +$7.51M | ﹤0.01% | 2100 |
|
|
2021
Q1 | $7.25M | Sell |
186,658
-5,263
| -3% | -$205K | ﹤0.01% | 2582 |
|
|
2020
Q4 | $11.9M | Buy |
191,921
+155,727
| +430% | +$9.65M | ﹤0.01% | 2046 |
|
|
2020
Q3 | $1.17M | Buy |
+36,194
| New | +$1.17M | ﹤0.01% | 3148 |
|